Responsibility in Drug Advertising Act of 2024

Cost and committee reports

Official records Congress.gov attaches to H.R. 9142.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. DeLAURO, as printed in the Congressional Record (Vol. 170, No. 121, July 25, 2024, Page H4949):
  Article 1, Section 8, Clauses 3 and 18 of the United States Constitution. The single subject of this legislation is: to prohibit direct-to-consumer advertising of a drug in the first three years after the drug's approval.
  Source: Congress.gov, Congressional Record July 25, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  221 characters

  Congress.gov bill record

  H.R. 9142, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/9142

  Record last updated by Congress.gov

  September 25, 2024

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  f270b30e8afda2149d7ba5d5ff58ecd45e24a8f598f16cec264217a94ebae7c8

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of September 25, 2024). Not every bill gets one.

From the Congress.gov bill record for H.R. 9142, last updated September 25, 2024. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.